SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.925
EU - Europa 1.931
AS - Asia 1.384
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
OC - Oceania 1
Totale 11.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.905
CN - Cina 760
UA - Ucraina 547
DE - Germania 437
TR - Turchia 337
IT - Italia 330
SG - Singapore 267
GB - Regno Unito 262
FI - Finlandia 131
SE - Svezia 114
FR - Francia 31
RU - Federazione Russa 30
BE - Belgio 26
CA - Canada 20
IN - India 7
CZ - Repubblica Ceca 6
IR - Iran 6
HR - Croazia 3
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
JP - Giappone 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
IE - Irlanda 1
IQ - Iraq 1
KR - Corea 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
Totale 11.246
Salva come PNG Salva come JPEG
Città #
Fairfield 1.109
Woodbridge 1.076
Houston 652
Jacksonville 612
Ann Arbor 559
Chandler 526
Ashburn 523
Seattle 401
Wilmington 392
Cambridge 352
Singapore 196
Izmir 193
Nanjing 177
Beijing 169
Milan 123
Princeton 118
San Diego 109
Boardman 101
New York 79
Shanghai 70
Dearborn 56
Nanchang 56
Shenyang 51
Falls Church 44
Los Angeles 37
Bremen 34
Hebei 32
Auburn Hills 29
Jiaxing 29
Munich 29
Changsha 28
Ferrara 28
Mountain View 27
San Mateo 27
Santa Clara 27
Jinan 26
Brussels 25
Tianjin 23
Mcallen 22
Norwalk 22
Philadelphia 20
Redwood City 20
Addison 19
Helsinki 18
Kunming 17
Montréal 17
Zhengzhou 17
Indiana 12
Ningbo 12
Tappahannock 12
Des Moines 10
London 10
Augusta 7
Düsseldorf 7
Verona 7
Florence 6
Hounslow 6
Lanzhou 6
Leawood 6
Orange 6
Redmond 6
Washington 6
Bologna 5
Guangzhou 5
Ardabil 4
Brno 4
Changchun 4
Hangzhou 4
Monmouth Junction 4
Prescot 4
Taizhou 4
Chiswick 3
Edinburgh 3
Ferrara di Monte Baldo 3
Fuzhou 3
Hefei 3
Zagreb 3
Bolzano 2
Bondeno 2
Brescia 2
Busto Arsizio 2
Chongqing 2
Montechiarugolo 2
New Bedfont 2
Olomouc 2
Portici 2
San Francisco 2
Seregno 2
Sofia 2
Southwark 2
Turin 2
Venice 2
Wandsworth 2
Acton 1
Asciano 1
Athens 1
Bari 1
Bordeaux 1
Boston 1
Caen 1
Totale 8.531
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 200
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 162
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 160
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 146
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 144
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 143
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 141
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 138
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 136
A new selective antagonist of the nociceptin receptor 136
Pharmacological characterization of nociceptin receptor: an in vitro study 133
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 131
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 128
A new ligand for the urotensin II receptor 127
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 127
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 126
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 126
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 124
Effects of vasoactive agents in healthy and diseased human saphenous veins 122
Ala scan analogues of HOE 140. Synthesis and biological activities 119
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 119
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 116
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 115
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 115
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 115
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 114
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 114
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 111
null 111
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 110
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 110
Structure-activity study at positions 3 and 4 of human neuropeptide S. 110
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 109
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 108
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 108
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 108
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 106
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 106
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 106
Pharmacological characterisation of novel kinin B2 receptor ligands 105
B1 and B2 kinin receptors in various species 105
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 105
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 105
Characterization of endothelin receptors in the human umbilical artery and vein 104
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 104
Pharmacology of the Kallikrein-Kinin system 104
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 103
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 103
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 103
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 102
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 102
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 101
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 100
null 99
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 99
null 98
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 98
Receptors for kinins in the human isolated umbilical vein. 98
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 98
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 98
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 97
Structure-activity relationship study on human urotensin II 97
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 96
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 96
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 96
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 94
Nociceptin/orphanin FQ receptor ligands, 93
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 93
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 92
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 92
null 92
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 90
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 90
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 90
Pharmacology of nociceptin and its receptor: a novel therapeutic target 89
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 89
null 88
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 87
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 86
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 86
null 84
Characterization of the human vascular kinin B2 receptor by binding assays. 82
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 82
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 81
Highly potent full and partial agonists and anatagonists of the nociceptin/orphanin FQ receptor 79
null 79
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 78
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 78
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 77
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 77
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 75
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 75
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 75
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 74
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 71
Identificazione di un antagonista del recettore UT 68
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 68
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 66
Totale 10.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.169 0 0 86 374 182 312 224 287 219 262 145 78
2020/20211.495 142 158 60 214 68 159 53 177 30 166 204 64
2021/20221.308 44 137 96 98 87 56 73 72 57 94 123 371
2022/20231.347 126 52 62 173 225 177 113 100 199 7 68 45
2023/2024641 77 78 38 16 41 137 21 42 13 13 14 151
2024/2025286 55 51 180 0 0 0 0 0 0 0 0 0
Totale 11.348